Avadel Pharmaceuticals (AVDL) Other Gross PP&E Adjustments (2016 - 2022)
Historic Other Gross PP&E Adjustments for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to -$6.4 million.
- Avadel Pharmaceuticals' Other Gross PP&E Adjustments rose 542.27% to -$6.4 million in Q3 2022 from the same period last year, while for Dec 2022 it was -$12.5 million, marking a year-over-year decrease of 15688.24%. This contributed to the annual value of -$4.9 million for FY2021, which is 2384.58% down from last year.
- As of Q3 2022, Avadel Pharmaceuticals' Other Gross PP&E Adjustments stood at -$6.4 million, which was up 542.27% from -$5.4 million recorded in Q2 2022.
- In the past 5 years, Avadel Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of -$2.2 million in Q2 2021 and a low of -$12.6 million during Q3 2018
- In the last 5 years, Avadel Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$5.2 million in 2019 and averaged -$5.6 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Other Gross PP&E Adjustments plummeted by 40907.88% in 2018, and later surged by 5866.13% in 2019.
- Over the past 5 years, Avadel Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$3.8 million in 2018, then surged by 37.26% to -$2.4 million in 2019, then tumbled by 67.46% to -$3.9 million in 2020, then dropped by 23.85% to -$4.9 million in 2021, then crashed by 30.4% to -$6.4 million in 2022.
- Its last three reported values are -$6.4 million in Q3 2022, -$5.4 million for Q2 2022, and -$9.5 million during Q1 2022.